Stacey Antar

Vice President, General Counsel

Stacey Antar is responsible for all Ferring US legal affairs.

Stacey has more than 25 years of experience in life sciences law. Prior to joining Ferring in 2014, Stacey was counsel for Johnson & Johnson for 18 years where she provided legal counsel in both the pharmaceutical and medical device sectors. Stacey served as Vice President, Law and served as a member of the global management board for Ortho-Clinical Diagnostics. Throughout her time at Johnson & Johnson, she served as a member of executive leadership teams for several operating companies and the law department’s Diversity and Inclusion committee. Stacey began her legal career as a patent attorney at Finnegan, Henderson, Farabow, Garrett & Dunner in Washington, D.C.

Stacey received her J.D. from Columbus School of Law, Catholic University of America in Washington, D.C. She earned her B.S. summa cum laude from the University of Massachusetts, Amherst. In 2016 Stacey was a recipient of the Women of Power & Influence Award by National Organization for Women NY.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience.

©2008-2019 Ferring Pharmaceuticals.  US--1900006